Socioeconomic status and risk of cardiovascular disease in 20 low-income, middle-income, and high-income countries: the Prospective Urban Rural Epidemiologic (PURE) study.


Journal

The Lancet. Global health
ISSN: 2214-109X
Titre abrégé: Lancet Glob Health
Pays: England
ID NLM: 101613665

Informations de publication

Date de publication:
06 2019
Historique:
received: 30 04 2018
revised: 28 12 2018
accepted: 30 01 2019
pubmed: 28 4 2019
medline: 27 5 2020
entrez: 28 4 2019
Statut: ppublish

Résumé

Socioeconomic status is associated with differences in risk factors for cardiovascular disease incidence and outcomes, including mortality. However, it is unclear whether the associations between cardiovascular disease and common measures of socioeconomic status-wealth and education-differ among high-income, middle-income, and low-income countries, and, if so, why these differences exist. We explored the association between education and household wealth and cardiovascular disease and mortality to assess which marker is the stronger predictor of outcomes, and examined whether any differences in cardiovascular disease by socioeconomic status parallel differences in risk factor levels or differences in management. In this large-scale prospective cohort study, we recruited adults aged between 35 years and 70 years from 367 urban and 302 rural communities in 20 countries. We collected data on families and households in two questionnaires, and data on cardiovascular risk factors in a third questionnaire, which was supplemented with physical examination. We assessed socioeconomic status using education and a household wealth index. Education was categorised as no or primary school education only, secondary school education, or higher education, defined as completion of trade school, college, or university. Household wealth, calculated at the household level and with household data, was defined by an index on the basis of ownership of assets and housing characteristics. Primary outcomes were major cardiovascular disease (a composite of cardiovascular deaths, strokes, myocardial infarction, and heart failure), cardiovascular mortality, and all-cause mortality. Information on specific events was obtained from participants or their family. Recruitment to the study began on Jan 12, 2001, with most participants enrolled between Jan 6, 2005, and Dec 4, 2014. 160 299 (87·9%) of 182 375 participants with baseline data had available follow-up event data and were eligible for inclusion. After exclusion of 6130 (3·8%) participants without complete baseline or follow-up data, 154 169 individuals remained for analysis, from five low-income, 11 middle-income, and four high-income countries. Participants were followed-up for a mean of 7·5 years. Major cardiovascular events were more common among those with low levels of education in all types of country studied, but much more so in low-income countries. After adjustment for wealth and other factors, the HR (low level of education vs high level of education) was 1·23 (95% CI 0·96-1·58) for high-income countries, 1·59 (1·42-1·78) in middle-income countries, and 2·23 (1·79-2·77) in low-income countries (p Although people with a lower level of education in low-income and middle-income countries have higher incidence of and mortality from cardiovascular disease, they have better overall risk factor profiles. However, these individuals have markedly poorer health care. Policies to reduce health inequities globally must include strategies to overcome barriers to care, especially for those with lower levels of education. Full funding sources are listed at the end of the paper (see Acknowledgments).

Sections du résumé

BACKGROUND
Socioeconomic status is associated with differences in risk factors for cardiovascular disease incidence and outcomes, including mortality. However, it is unclear whether the associations between cardiovascular disease and common measures of socioeconomic status-wealth and education-differ among high-income, middle-income, and low-income countries, and, if so, why these differences exist. We explored the association between education and household wealth and cardiovascular disease and mortality to assess which marker is the stronger predictor of outcomes, and examined whether any differences in cardiovascular disease by socioeconomic status parallel differences in risk factor levels or differences in management.
METHODS
In this large-scale prospective cohort study, we recruited adults aged between 35 years and 70 years from 367 urban and 302 rural communities in 20 countries. We collected data on families and households in two questionnaires, and data on cardiovascular risk factors in a third questionnaire, which was supplemented with physical examination. We assessed socioeconomic status using education and a household wealth index. Education was categorised as no or primary school education only, secondary school education, or higher education, defined as completion of trade school, college, or university. Household wealth, calculated at the household level and with household data, was defined by an index on the basis of ownership of assets and housing characteristics. Primary outcomes were major cardiovascular disease (a composite of cardiovascular deaths, strokes, myocardial infarction, and heart failure), cardiovascular mortality, and all-cause mortality. Information on specific events was obtained from participants or their family.
FINDINGS
Recruitment to the study began on Jan 12, 2001, with most participants enrolled between Jan 6, 2005, and Dec 4, 2014. 160 299 (87·9%) of 182 375 participants with baseline data had available follow-up event data and were eligible for inclusion. After exclusion of 6130 (3·8%) participants without complete baseline or follow-up data, 154 169 individuals remained for analysis, from five low-income, 11 middle-income, and four high-income countries. Participants were followed-up for a mean of 7·5 years. Major cardiovascular events were more common among those with low levels of education in all types of country studied, but much more so in low-income countries. After adjustment for wealth and other factors, the HR (low level of education vs high level of education) was 1·23 (95% CI 0·96-1·58) for high-income countries, 1·59 (1·42-1·78) in middle-income countries, and 2·23 (1·79-2·77) in low-income countries (p
INTERPRETATION
Although people with a lower level of education in low-income and middle-income countries have higher incidence of and mortality from cardiovascular disease, they have better overall risk factor profiles. However, these individuals have markedly poorer health care. Policies to reduce health inequities globally must include strategies to overcome barriers to care, especially for those with lower levels of education.
FUNDING
Full funding sources are listed at the end of the paper (see Acknowledgments).

Identifiants

pubmed: 31028013
pii: S2214-109X(19)30045-2
doi: 10.1016/S2214-109X(19)30045-2
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e748-e760

Commentaires et corrections

Type : CommentIn

Informations de copyright

Copyright © 2019 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY-NC-ND 4.0 license. Published by Elsevier Ltd.. All rights reserved.

Auteurs

Annika Rosengren (A)

Department of Molecular and Clinical Medicine, Sahlgrenska Academy, University of Gothenburg and Sahlgrenska University Hospital, Gothenburg, Sweden. Electronic address: annika.rosengren@gu.se.

Andrew Smyth (A)

HRB Clinical Research Facility Galway, National University of Ireland, Galway, Ireland.

Sumathy Rangarajan (S)

Population Health Research Institute, McMaster University, Hamilton Health Sciences Centre, Hamilton, ON, Canada.

Chinthanie Ramasundarahettige (C)

Population Health Research Institute, McMaster University, Hamilton Health Sciences Centre, Hamilton, ON, Canada.

Shrikant I Bangdiwala (SI)

Population Health Research Institute, McMaster University, Hamilton Health Sciences Centre, Hamilton, ON, Canada.

Khalid F AlHabib (KF)

Department of Cardiac Sciences, King Fahad Cardiac Center, College of Medicine, King Saud University, Riyadh, Saudi Arabia.

Alvaro Avezum (A)

Dante Pazzanese Institute of Cardiology and University Santo Amaro, São Paulo, Brazil.

Kristina Bengtsson Boström (K)

R&D Centre Skaraborg Primary Care, Skövde, Sweden.

Jephat Chifamba (J)

Department of Physiology, University of Zimbabwe College of Health Sciences, Harare, Zimbabwe.

Sadi Gulec (S)

Cardiology Department, Ankara University School of Medicine, Ankara, Turkey.

Rajeev Gupta (R)

Eternal Heart Care Centre and Research Institute, Jaipur, India.

Ehi U Igumbor (EU)

School of Public Health, University of the Western Cape, Bellville, South Africa.

Romaina Iqbal (R)

Department of Community Health Sciences, Aga Khan University, Karachi, Pakistan.

Norhassim Ismail (N)

Department of Community Health, Faculty of Medicine, University Kebangsaan Malaysia, Kuala Lumpur, Malaysia.

Philip Joseph (P)

Population Health Research Institute, McMaster University, Hamilton Health Sciences Centre, Hamilton, ON, Canada.

Manmeet Kaur (M)

School of Public Health, Post Graduate Institute of Medical Education and Research, Chandigarh, India.

Rasha Khatib (R)

Public Health Sciences, Stritch School of Medicine, Maywood, IL, USA.

Iolanthé M Kruger (IM)

Africa Unit for Transdisciplinary Health Research, North-West University, Potchefstroom, South Africa.

Pablo Lamelas (P)

Population Health Research Institute, McMaster University, Hamilton Health Sciences Centre, Hamilton, ON, Canada.

Fernando Lanas (F)

Universidad de La Frontera, Temuco, Chile.

Scott A Lear (SA)

Faculty of Health Sciences, Simon Fraser University, Vancouver, BC, Canada.

Wei Li (W)

State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Disease, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, China.

Chuangshi Wang (C)

State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Disease, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, China.

Deren Quiang (D)

Wujin District Center for Disease Control and Prevention, Changzhou, China.

Yang Wang (Y)

State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Disease, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, China.

Patricio Lopez-Jaramillo (P)

Research Institute, FOSCAL International Clinic, Bucaramanga, Colombia; Eugenio Espejo Medical School, Universidad UTE, Quito, Ecuador.

Noushin Mohammadifard (N)

Isfahan Cardiovascular Research Center, Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran.

Viswanathan Mohan (V)

Madras Diabetes Research Foundation and Dr Mohan's Diabetes Specialities Centre, Chennai, India.

Prem K Mony (PK)

St John's Medical College & Research Institute, Bangalore, India.

Paul Poirier (P)

Faculté de pharmacie, Université Laval, Institut universitaire de cardiologie et de pneumologie de Québec, Québec City, QC, Canada.

Sarojiniamma Srilatha (S)

Health Action by People, Kerala, India.

Andrzej Szuba (A)

Division of Angiology, Wroclaw Medical University, Wroclaw, Poland.

Koon Teo (K)

Population Health Research Institute, McMaster University, Hamilton Health Sciences Centre, Hamilton, ON, Canada.

Andreas Wielgosz (A)

Department of Medicine, The Ottawa Hospital, Ottawa, ON, Canada.

Karen E Yeates (KE)

Department of Medicine, Queen's University, Kingston, ON, Canada.

Khalid Yusoff (K)

Universiti Teknologi MARA, Selayang Campus, Selangor, Malaysia; UCSI University, Kuala Lumpur, Malaysia.

Rita Yusuf (R)

School of Life Sciences, Independent University, Dhaka, Bangladesh.

Afzalhusein H Yusufali (AH)

Hatta Hospital, Dubai Medical College, Dubai Health Authority, Dubai, United Arab Emirates.

Marjan W Attaei (MW)

Population Health Research Institute, McMaster University, Hamilton Health Sciences Centre, Hamilton, ON, Canada.

Martin McKee (M)

London School of Hygiene & Tropical Medicine, London, UK.

Salim Yusuf (S)

Population Health Research Institute, McMaster University, Hamilton Health Sciences Centre, Hamilton, ON, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH